What is Levalbuterol Hydrochloride?
Levalbuterol hydrochloride is a bronchodilator medication used to treat or prevent bronchospasm in adults and children aged 6 years and older who have asthma [1]. It is a short-acting beta2-adrenergic agonist that works by relaxing the muscles in the airways, making it easier to breathe [1]. The medication is typically administered via an inhaler [1].
When Was Levalbuterol Hydrochloride Patented?
The initial patent for levalbuterol hydrochloride was granted in 1997 [2]. Patents for pharmaceutical products can vary in their duration and scope, and multiple patents can cover different aspects of a drug, such as its synthesis, formulation, or method of use [3]. Information on specific patent expiry dates can be found on specialized databases like DrugPatentWatch.com [4].
How Does Levalbuterol Hydrochloride Work?
Levalbuterol hydrochloride functions by selectively activating beta2-adrenergic receptors in the smooth muscles of the lungs [1]. This activation leads to a cascade of intracellular events that ultimately cause muscle relaxation, widening the airways [1]. This relief from airway constriction is the primary mechanism by which it alleviates asthma symptoms like wheezing and shortness of breath [1].
What are the Risks and Side Effects of Levalbuterol Hydrochloride?
Common side effects associated with levalbuterol hydrochloride include headache, dizziness, tremors, and nervousness [1]. Less common but potentially serious side effects can involve an increased heart rate, palpitations, and changes in blood pressure [1]. Patients with pre-existing heart conditions or hypersensitivity to beta2-agonists should use this medication with caution [1].
Are There Other Medications Similar to Levalbuterol Hydrochloride?
Yes, there are other short-acting beta2-agonists used for asthma treatment, such as albuterol [5]. Levalbuterol is the R-enantiomer of albuterol, meaning it is a specific stereoisomer [5]. Some research suggests that levalbuterol may have a more favorable safety profile with fewer side effects compared to racemic albuterol, which contains both R and S enantiomers [5]. However, comparative effectiveness can vary among individuals [5].
What is the Current Status of Levalbuterol Hydrochloride's Patent and Market Exclusivity?
The patent landscape for pharmaceutical drugs is complex and dynamic. While the initial patent was granted in 1997, subsequent patents and market exclusivity periods can influence the availability of generic versions [3, 4]. Information regarding the exact expiry of patents and the potential for generic entry can be accessed through resources like DrugPatentWatch.com [4].
How is Levalbuterol Hydrochloride Regulated?
Levalbuterol hydrochloride is regulated by health authorities such as the U.S. Food and Drug Administration (FDA) [1]. These agencies review clinical trial data to ensure the drug's safety and efficacy before approving it for medical use [1]. Ongoing post-market surveillance monitors for adverse events and ensures continued compliance with regulatory standards [1].
---
Sources:
[1] https://www.drugpatentwatch.com/levalbuterol-hydrochloride/
[2] https://www.drugpatentwatch.com/levalbuterol-hydrochloride/patents
[3] https://www.drugpatentwatch.com/understanding-drug-patents
[4] https://www.drugpatentwatch.com/
[5] https://www.drugpatentwatch.com/albuterol-vs-levalbuterol